Tumor cell surface levels of DR, furthermore, do not necessarily correlate with sensitivity to the death signal.23 Since we showed that 2DG treatment did not regulate DR4 levels, enhanced TRAIL sensitivity in the absence of DR5 suggested that 2DG must have other effects downstream of DRs in these cancer cells. The gene discussed is TNFRSF10A; the disease is neoplasm.